
Ofloxacin (50mg) + Metronidazole (100mg)
Active composition
+1 more active ingredient
Ofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their death.
Medical applications
Naxiflox MZ Oral Suspension is a combined antibacterial medication containing Ofloxacin (50mg) and Metronidazole (100mg) per 5mL. Indicated for the treatment of various bacterial infections, including skin and skin structure infections, genitourinary tract infections, intra-abdominal infections, and respiratory tract infections caused by susceptible organisms. Ofloxacin, a fluoroquinolone, exhibits a broad spectrum of antibacterial activity, while Metronidazole is effective against anaerobic and microaerophilic bacteria. The dosage and duration of therapy should be determined by the prescriber, based on the specific infection and patient's condition. It is essential to complete the full course of therapy to ensure effective treatment and minimize the risk of treatment failure or recurrence.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Naxiflox MZ Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment of Naxiflox MZ Oral Suspension may be needed. Please consult your doctor.
Exercise Caution
Naxiflox MZ Oral Suspension should be used with caution in patients with liver disease. Dose adjustment of Naxiflox MZ Oral Suspension may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Naxiflox MZ Oral Suspension

Ofloxacin (50mg) + Metronidazole (100mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Ofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their death.
Medical applications
Naxiflox MZ Oral Suspension is a combined antibacterial medication containing Ofloxacin (50mg) and Metronidazole (100mg) per 5mL. Indicated for the treatment of various bacterial infections, including skin and skin structure infections, genitourinary tract infections, intra-abdominal infections, and respiratory tract infections caused by susceptible organisms. Ofloxacin, a fluoroquinolone, exhibits a broad spectrum of antibacterial activity, while Metronidazole is effective against anaerobic and microaerophilic bacteria. The dosage and duration of therapy should be determined by the prescriber, based on the specific infection and patient's condition. It is essential to complete the full course of therapy to ensure effective treatment and minimize the risk of treatment failure or recurrence.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Naxiflox MZ Oral Suspension should be used with caution in patients with kidney disease. Dose adjustment of Naxiflox MZ Oral Suspension may be needed. Please consult your doctor.
Exercise Caution
Naxiflox MZ Oral Suspension should be used with caution in patients with liver disease. Dose adjustment of Naxiflox MZ Oral Suspension may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Naxiflox MZ Oral Suspension















